Good Leaver, Bad Leaver: Why Investments and Share Schemes Complicate the Goodbye
Many companies issue shares or share options to attract and reward the key individuals who...Learn More
April 23, 2021
In response to the COVID-19 crisis the Government, in conjunction with the British Business Bank, set up Future Fund to provide fast-growth businesses with £1 billion of convertible loans. Stephenson Law was pleased to support a number of companies in successfully securing millions of pounds of funding under this scheme.
In recognition of the importance of the UK's tech sector and the success of Future Fund, Rishi Sunak announced Future Fund: Breakthrough in the March budget. The new scheme, which is expected to launch in early summer, will provide £375m of funding on a matched-funding basis to UK-based R&D intensive companies. It will be delivered again by the British Business Bank, but through a commercial subsidiary called British Patient Capital.
The details are to be confirmed, but we expect that British Patient Capital and private co-investors will subscribe for shares directly instead of making convertible loans.
As with Future Fund the application process will be led by investors, although there may be additional requirements as to the type of investor that can lead the process as the minimum size of the investment round for Future Fund: Breakthrough is £20 million (as opposed to the £250,000 minimum under Future Fund).
We will provide further details of Future Fund: Breakthrough once they are available.
We're the corporate law experts in helping you plan the next route of your journey. Find out more about our corporate law offering here.